4//SEC Filing
Axovant Sciences Ltd. 4
Accession 0001209191-17-029468
CIK 0001636050operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 8:58 PM ET
Size
10.1 KB
Accession
0001209191-17-029468
Insider Transaction Report
Form 4
Adasczik Michael
Principal Accounting Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-04-28+12,500→ 12,500 totalExercise: $24.24Exp: 2027-04-28→ Common Shares (12,500 underlying)
Footnotes (2)
- [F1]This option vests over a period of four years, with one quarter of the common shares underlying the option vesting on April 28, 2018 and the remainder vesting in twelve equal quarterly installments thereafter. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F2]Includes only options with the same termination date.
Issuer
Axovant Sciences Ltd.
CIK 0001636050
Entity typeoperating
Related Parties
1- filerCIK 0001636050
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 8:58 PM ET
- Size
- 10.1 KB